Life Science Company News

Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Hospital Infection Therapeutics Market size is set to grow by USD 3.46 billion from 2024-2028, Increase in incidence and prevalence of respiratory disorders boost the market, Technavio

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2024

Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo Co-Formulated with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2024

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2024

Dry Eye Syndrome Drugs Market size is set to grow by USD 2.13 billion from 2024-2028, Growing geriatric population boost the market, Technavio

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2024

Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease

Read more ››
By: GlobeNewswire - 21 Jun 2024

Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2

Read more ››
By: GlobeNewswire - 21 Jun 2024

Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome

Read more ››
By: GlobeNewswire - 21 Jun 2024

Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27

Read more ››
By: GlobeNewswire - 21 Jun 2024

Acasti Announces Year-End 2024 Financial Results, Provides Business Update

Read more ››
By: GlobeNewswire - 21 Jun 2024

Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor, on Monday, June 24, 2024

Read more ››
By: GlobeNewswire - 21 Jun 2024

Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes

Read more ››
By: GlobeNewswire - 21 Jun 2024

Starton Therapeutics Announces 100% Partial Response or Better in Multiple Myeloma Patients in Interim, Top-line Data from STAR-LLD Phase 1b Clinical Trial

Read more ››
By: GlobeNewswire - 21 Jun 2024

Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences

Read more ››
By: GlobeNewswire - 21 Jun 2024

Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting

Read more ››
By: GlobeNewswire - 21 Jun 2024

Sharecare enters into definitive agreement to be acquired by Altaris

Read more ››
By: GlobeNewswire - 21 Jun 2024

Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing

Read more ››
By: GlobeNewswire - 21 Jun 2024

BioSenic signs a new subscription agreement for a maximum of EUR 2.1M in convertible bonds

Read more ››
By: GlobeNewswire - 21 Jun 2024

ALK provides update on regulatory process for the house dust mite allergy tablet in China

Read more ››
By: GlobeNewswire - 21 Jun 2024

ALK upgrades its full-year revenue and earnings outlook

Read more ››
By: GlobeNewswire - 21 Jun 2024

Inozyme Pharma Announces Presentation and Sponsored Symposium at the 11th International Conference on Children’s Bone Health (ICCBH)

Read more ››
By: GlobeNewswire - 21 Jun 2024
Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate